Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives

Microdosing—repeated, intermittent ingestion of sub-perceptual amounts of psychedelics such as LSD, psilocybin, and DMT—has emerged as a social trend and potential therapeutic intervention, yet its effects remain largely unexplored in formal research. Unlike macrodosing, which produces full-blown psychedelic experiences, microdosing aims to maintain or improve cognitive and mental function without disrupting daily routines. Informal accounts suggest benefits for mental disorders, creativity, cognition, and personal growth, but controlled studies are scarce. This article synthesizes clinical, social, and cultural dimensions of microdosing, examining why the practice is gaining popularity, weighing potential benefits and risks, and discussing sociocultural implications. It also compares macro- and microdose effects on behavior and psychopathology in relation to dosage and context.

Study at a glance

Abstract

To date, the clinical and scientific literature has best documented the effects of classical psychedelics, such as lysergic acid diethylamide (LSD), psilocybin, and dimethyltryptamine (DMT), in typical quantities most often associated with macrodosing. More recently, however, microdosing with psychedelics has emerged as a social trend and nascent therapeutic intervention. This variation in psychedelic practice refers to repeat, intermittent ingestion of less-than-macrodose amounts that do not cause the effects associated with full-blown “trips”. Microdosing paves the road to incorporating psychedelic drugs into a daily routine while maintaining, or even improving, cognitive and mental function. Unlike macrodosing with psychedelics, the influence of microdosing remains mostly unexplored. And yet, despite the paucity of formal studies, many informal accounts propose that microdosing plays an important role as both a therapeutic intervention (e.g., in mental disorders) and enhancement tool (e.g., recreationally—to boost creativity, improve cognition, and drive personal growth). In response to this relatively new practice, we provide an integrative synthesis of the clinical, social, and cultural dimensions of microdosing. We describe some of the overarching context that explains why this practice is increasingly in vogue, unpack potential benefits and risks, and comment on sociocultural implications. In addition, this article considers the effects that macro- and microdoses have on behavior and psychopathology in light of their dosage characteristics and contexts of use.